Z Mujagic1, D Keszthelyi1, Q Aziz2, W Reinisch3,4, E G Quetglas5, F De Leonardis5, M Segerdahl5,6, A A M Masclee1. 1. Division Gastroenterology-Hepatology, Department of Internal Medicine, NUTRIM School for Nutrition and Translational Research in Metabolism, Maastricht University Medical Center+, Maastricht, The Netherlands. 2. Centre for Digestive Diseases, Blizard Institute of Cell & Molecular Science, Wingate Institute of Neurogastroenterology, Barts and the London School of Medicine & Dentistry, Queen Mary University of London, London, UK. 3. Department Internal Medicine III, Medical University of Vienna, Vienna, Austria. 4. McMaster University, Hamilton, ON, Canada. 5. Medical Intelligence, Early Clinical Development, Grünenthal GmBH, Aachen, Germany. 6. Department of Physiology and Pharmacology, Karolinska Institute, Stockholm, Sweden.
Abstract
BACKGROUND: Consensus on standard methods to assess chronic abdominal pain in patients with irritable bowel syndrome (IBS) is currently lacking. AIM: To systematically review the literature with respect to instruments of measurement of chronic abdominal pain in IBS patients. METHODS: Systematic literature search was performed in PubMed/Medline databases for studies using pain measurement instruments in patients with IBS. RESULTS: One hundred and ten publications were reviewed. A multitude of different instruments is currently used to assess chronic abdominal pain in IBS patients. The single-item methods, e.g. the validated 10-point numeric rating scale (NRS), and questionnaires assessing gastrointestinal symptoms severity, focus mostly on the assessment of only the intensity of abdominal pain. Of these questionnaires, the validated IBS-Symptom Severity Scale includes the broadest measurement of pain-related aspects. General pain questionnaires and electronic momentary symptom assessment tools have been used to study abdominal pain in IBS patients, but have not yet been validated for this purpose. The evidence for the use of provocation tests, e.g. the rectal barostat with balloon distention, for measurement of abdominal pain in IBS is weak, due to the poor correlation between visceral pain thresholds assessed by provocation tests and abdominal pain as assessed by retrospective questionnaires. CONCLUSIONS: The multitude of different instruments to measure chronic abdominal pain in IBS makes it difficult to compare endpoints of published studies. There is need for validated instruments to assess chronic abdominal pain in IBS patients, that overcome the limitations of the currently available methods.
BACKGROUND: Consensus on standard methods to assess chronic abdominal pain in patients with irritable bowel syndrome (IBS) is currently lacking. AIM: To systematically review the literature with respect to instruments of measurement of chronic abdominal pain in IBS patients. METHODS: Systematic literature search was performed in PubMed/Medline databases for studies using pain measurement instruments in patients with IBS. RESULTS: One hundred and ten publications were reviewed. A multitude of different instruments is currently used to assess chronic abdominal pain in IBS patients. The single-item methods, e.g. the validated 10-point numeric rating scale (NRS), and questionnaires assessing gastrointestinal symptoms severity, focus mostly on the assessment of only the intensity of abdominal pain. Of these questionnaires, the validated IBS-Symptom Severity Scale includes the broadest measurement of pain-related aspects. General pain questionnaires and electronic momentary symptom assessment tools have been used to study abdominal pain in IBS patients, but have not yet been validated for this purpose. The evidence for the use of provocation tests, e.g. the rectal barostat with balloon distention, for measurement of abdominal pain in IBS is weak, due to the poor correlation between visceral pain thresholds assessed by provocation tests and abdominal pain as assessed by retrospective questionnaires. CONCLUSIONS: The multitude of different instruments to measure chronic abdominal pain in IBS makes it difficult to compare endpoints of published studies. There is need for validated instruments to assess chronic abdominal pain in IBS patients, that overcome the limitations of the currently available methods.
Authors: Lisa Vork; Zlatan Mujagic; Marjan Drukker; Daniel Keszthelyi; José M Conchillo; Martine A M Hesselink; Jim van Os; Ad A M Masclee; Carsten Leue; Joanna W Kruimel Journal: Neurogastroenterol Motil Date: 2018-11-20 Impact factor: 3.598
Authors: Johannes Peter; Camille Fournier; Marija Durdevic; Lukas Knoblich; Bettina Keip; Clemens Dejaco; Michael Trauner; Gabriele Moser Journal: Psychosom Med Date: 2018-10 Impact factor: 4.312
Authors: Zsa Zsa R M Weerts; Koert G E Heinen; Ad A M Masclee; Amber B A Quanjel; Bjorn Winkens; Lisa Vork; Paula E L M Rinkens; Daisy M A E Jonkers; Daniel Keszthelyi Journal: JMIR Mhealth Uhealth Date: 2020-11-02 Impact factor: 4.773
Authors: Asbjørn M Drewes; Anne E Olesen; Adam D Farmer; Eva Szigethy; Vinciane Rebours; Søren S Olesen Journal: Nat Rev Dis Primers Date: 2020-01-06 Impact factor: 52.329
Authors: Zlatan Mujagic; Ettje F Tigchelaar; Alexandra Zhernakova; Thomas Ludwig; Javier Ramiro-Garcia; Agnieszka Baranska; Morris A Swertz; Ad A M Masclee; Cisca Wijmenga; Frederik J van Schooten; Agnieszka Smolinska; Daisy M A E Jonkers Journal: Sci Rep Date: 2016-06-06 Impact factor: 4.379